These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15086994)

  • 1. FFPRHC Guidance (April 2004). The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health.
    Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
    J Fam Plann Reprod Health Care; 2004 Apr; 30(2):99-108; quiz 109. PubMed ID: 15086994
    [No Abstract]   [Full Text] [Related]  

  • 2. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
    Rose S; Chaudhari A; Peterson CM
    Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GyneFix-LNG: preliminary clinical experience with a copper and levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Dhont M; Temmerman M; Delbarge W; Schacht E; Thiery M
    Eur J Contracept Reprod Health Care; 1999 Mar; 4(1):15-9. PubMed ID: 10367191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes of Israeli gynecologists towards the levonorgestrel-releasing intrauterine system: a questionnaire survey.
    Ben-Haroush A; Oron G; Yogev Y; Yeshaya A; Kaplan B
    Eur J Contracept Reprod Health Care; 2004 Mar; 9(1):29-33. PubMed ID: 15352692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FFPRHC Guidance: emergency contraception (April 2003).
    Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
    J Fam Plann Reprod Health Care; 2003 Apr; 29(2):9-16. PubMed ID: 12681030
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic use of the LNG IUS, and counseling.
    Pakarinen P; Toivonen J; Luukkainen T
    Semin Reprod Med; 2001 Dec; 19(4):365-72. PubMed ID: 11727178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraception and treatment in the perimenopause with a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: an extended pilot study.
    Wildemeersch D; Schacht E; Wildemeersch P
    Contraception; 2002 Aug; 66(2):93-9. PubMed ID: 12204781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis.
    Qiu J; Cheng J; Wang Q; Hua J
    Med Sci Monit; 2014 Sep; 20():1700-13. PubMed ID: 25245843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levonorgestrel intrauterine system: the benefits of reduced bleeding.
    Cameron IT
    Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():27-32. PubMed ID: 11336431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
    Fong YF; Singh K
    Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception.
    Tariq N; Ayub R; Jaffery T; Rahim F; Naseem F; Kamal M
    J Coll Physicians Surg Pak; 2011 Apr; 21(4):210-3. PubMed ID: 21453616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
    Cihangir U; Ebru A; Murat E; Levent Y
    Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review.
    Ramhendar T; Byrne P
    Contraception; 2012 Sep; 86(3):288-9. PubMed ID: 22305914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malposition and expulsion of the levonorgestrel intrauterine system among women with inherited bleeding disorders.
    Rimmer E; Jamieson MA; James P
    Haemophilia; 2013 Nov; 19(6):933-8. PubMed ID: 23711358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland.
    Backman T; Huhtala S; Tuominen J; Luoto R; Erkkola R; Blom T; Rauramo I; Koskenvuo M
    Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():23-6. PubMed ID: 11336430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.